Your browser doesn't support javascript.
loading
The combination of lenalidomide and dexamethasone reduces bone resorption in responding patients with relapsed/refractory multiple myeloma but has no effect on bone formation: final results on 205 patients of the Greek myeloma study group.
Terpos, Evangelos; Christoulas, Dimitrios; Kastritis, Efstathios; Katodritou, Eirini; Papatheodorou, Athanasios; Pouli, Anastasia; Kyrtsonis, Marie-Christine; Michalis, Eurydiki; Papanikolaou, Xenophon; Gkotzamanidou, Maria; Koulieris, Efstathios; Gavriatopoulou, Maria; Zervas, Konstantinos; Dimopoulos, Meletios A.
Am J Hematol ; 89(1): 34-40, 2014 Jan.
Article in En | MEDLINE | ID: mdl-23983166
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteogenesis / Bone Resorption / Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Am J Hematol Year: 2014 Document type: Article Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteogenesis / Bone Resorption / Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Am J Hematol Year: 2014 Document type: Article Country of publication: